Senior Principal Scientist
Bristol Myers Squibb
Princeton, New Jersey
Kun Yang, Ph.D. is a Senior Principal Scientist at Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis (CPPDB) in Bristol Myers Squibb. At BMS, Kun is developing bioanalytical strategies for various biologics development programs, including cell (CAR-T) & gene therapy (AAV) molecules, antibodies, small molecule, etc. He is acting as the bioanalytical liaison with clinical, and non-clinical internal cross-functional project teams and external collaborators. He also leads the preparation of regulatory documents including IB, INDs, NDAs, and BLA submission documents and being responsible for responding to Health Authority queries related to bioanalysis. Kun received his Ph.D. in Biochemistry from University of Texas Southwestern Medical Center at Dallas.
Disclosure information not submitted.
AAPS Therapeutic Product Immunogenicity Community Membership Meeting
Tuesday, October 22, 2024
5:00 PM – 6:00 PM MT
Challenges in Critical Reagents and ADA Assays for Cell Therapy
Wednesday, October 23, 2024
3:30 PM – 3:45 PM MT